Cilnidipine is a unique Ca2+ channel blocker with an inhibitory action on the sympathetic N‐
type Ca2+ channels, which is used for patients with hypertension in Japan. Cilnidipine has …

US20080118564A1 - Pharmaceutical Composition Containing Candesartan Cilexetil as
Lipophilic Crystalline Substance - Google Patents US20080118564A1 - Pharmaceutical …

Cilazapril must be switched now – how to avoid ‘rocking the boat’ | New Zealand Doctor Skip to
main content User account menu Group Login Log in Subscribe Main navigation News All news …

Purpose Although cilnidipine and valsartan are widely coadministered to patients with
hypertension, their drug–drug interaction potential has not been investigated. This study …

Full article: Lercanidipine in worldwide usage Skip to Main Content Taylor and Francis
Online homepage Taylor and Francis Online homepage Log in | Register Cart 1.Home 2.All …

Candesartan cilexetil is a pharmacological compound belonging to the class of angiotensin
II receptor blockers (ARBs), which are widely used in the management of cardiovascular …

The absolute configuration of the monoclinic form of the title compound,(−)-5, 6, 9, 10-
tetrahydro-10-[(2-methyl-1H-imidazol-1-yl) methyl]-4H-pyrido [3, 2, 1-jk] carbazol-11 (8H) …

A new high performance liquid chromatography method was developed and validated for
the quantitation of Cilnidipine and Valsartan in pharmaceutical formulations. Determination …

A specific liquid chromatography–mass spectrometric (LC–MS/MS) assay was developed
and validated for the determination of lercanidipine, a dihydropyridine calcium channel …

Azelnidipine (CS-905) is a long-acting, once-daily, orally-administered calcium channel
antagonist which is being jointly developed by Sankyo and UBE. An NDA for the treatment of …